Bal Pharma P/B Ratio
Bal Pharma P/B ratio. Bal Pharma (BALPHARMA) P/B ratio is 2.04 (Moderate), book value per share ₹51.25 vs Healthcare average P/B of 0.01 — High - Premium to book value, growth expectations or asset-light model. For live price, earnings yield and the full fundamental profile, see BALPHARMA stock price BSE.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
BALPHARMA P/B Ratio — Valuation Insights & Book Value Analysis
Bal Pharma price-to-book ratio interpretation, valuation status and historical context — current P/B 2.04 (Moderate). View BALPHARMA 52-week chart for the annual high/low range and current price position.
- Trading at premium to sector average PB of 0.01
Bal Pharma P/B Ratio Historical Trend
BALPHARMA annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Analyse BALPHARMA shareholder distribution to track promoter, FII and institutional holdings.
BALPHARMA Historical P/B Ratio — Book Value Per Share & Year-End Price
Bal Pharma annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 2.06 | ₹51.25 | ₹105.74 | ₹82 | Moderate |
| 2025 | 1.52 | ₹48.12 | ₹73.32 | ₹77 | Moderate |
| 2024 | 2.72 | ₹45.0 | ₹122.62 | ₹72 | Moderate |
| 2023 | 2.5 | ₹40.0 | ₹100.05 | ₹64 | Moderate |
| 2022 | 2.32 | ₹39.33 | ₹91.15 | ₹59 | Moderate |
BALPHARMA vs Healthcare Peers — P/B Ratio Comparison
Bal Pharma P/B 2.04 vs Healthcare average 0.01, median 0.61 — range -6.55–1.07.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -1.2 | ₹35 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.8 | ₹147 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.19 | ₹50 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |